Ravi A. Madan, M.D.
Head, Prostate Cancer Clinical Research Section
Senior Clinician, Genitourinary Malignancies Branch
Program Director, Physician-Scientist Early Investigator Program
Center for Cancer Research, NCI, NIH
Bethesda, MD
Dr. Madan’s clinical research is focused on prostate cancer. A primary area of interest is to develop a better understanding of how immune stimulating therapies can improve clinical outcomes and be combined with other prostate cancer therapies. Currently, Dr. Madan is investigating the potential of immunocytokines in prostate cancer.
In addition, Dr. Madan is also evaluating treatments in patients with early recurrence of prostate cancer after definitive surgery or radiation (e.g. biochemical recurrence). These clinical trials include interventions such as immunotherapy, radiopharmaceuticals, and anti- androgens, but spare the use of testosterone lowering therapy (i.e.androgen deprivation therapy). Dr. Madan is also working to better define the role of PSMA PET imaging in recurrent prostate cancer. Dr. Madan is also the program director of CCR’s Physician-Scientist Early Investigator Program.
